Experimental IgA nephropathy in mice
- PMID: 3515045
Experimental IgA nephropathy in mice
Abstract
Based on a hint from an immunological abnormality found in human IgA nephropathy, we tried to make up an experimental IgA nephropathy in mice by administration of a food antigen for a long term with blockage of the reticuloendothelial system (RES). Mice were divided into three groups: group 1 had oral administration of lactalbumin (Lalb); group 2 was treated with colloidal carbon to block RES in addition to oral administration of lactalbumin; and group 3 was treated only with colloidal carbon for RES blockage. Renal biopsy was performed at 18 weeks after RES blockage and the animals were sacrified at 30 weeks for histopathological observation of renal tissue. The deposits of IgA in the mesangial area were not found in animals of groups 1 and 3 but 17.6% of group 2 at 18 weeks following RES blockage, also in no animal of group 1 but 91.7% of Group 2, and 15.4% of group 3 at 30 weeks. They were highly frequent in group 2 at 30 weeks (p less than 0.001). Observation under electron microscope also revealed a significant increase (p less than 0.001) of mesangial dense deposits in group 2 at 30 weeks, and formation of large dense deposits similar to those seen in human IgA nephropathy. Through observation over a period of time, an increase of mesangial IgA deposition and histopathological aggravation were confirmed. Serologically, serum level of IgA was significantly higher in group 2 (p less than 0.001) and was correlated with the intensity of mesangial IgA deposition. It was concluded that lesions very similar to human IgA nephropathy could be prepared in mice by inducing a dysfunction of RES as continuous oral immunization.
Similar articles
-
Effect of sodium cromoglycate on an experimental model of IgA nephropathy.Clin Nephrol. 1987 Mar;27(3):141-6. Clin Nephrol. 1987. PMID: 3105940
-
Antigen as mediator of glomerular injury in experimental IgA nephropathy.Lab Invest. 1991 Apr;64(4):508-19. Lab Invest. 1991. PMID: 2016857
-
The role of mesangial complement in the hematuria of experimental IgA nephropathy.Lab Invest. 1987 Sep;57(3):269-76. Lab Invest. 1987. PMID: 3306149
-
[Immunopathology of glomerulonephritis with mesangial IgA deposits].Nephrologie. 1989;10(4):169-74. Nephrologie. 1989. PMID: 2699007 Review. French.
-
IgA nephropathy: lessons from an animal model, the ddY mouse.J Nephrol. 2008 Jul-Aug;21(4):463-7. J Nephrol. 2008. PMID: 18651534 Review.
Cited by
-
Effects of neutral pepsin on the deposition of dietary antigens in glomeruli from IgA nephropathy.Clin Exp Immunol. 1990 Jul;81(1):137-41. doi: 10.1111/j.1365-2249.1990.tb05304.x. Clin Exp Immunol. 1990. PMID: 2116246 Free PMC article.
-
Immunopathogenesis of experimental IgA nephropathy.Springer Semin Immunopathol. 1994;16(1):81-95. doi: 10.1007/BF00196716. Springer Semin Immunopathol. 1994. PMID: 7997949 Review. No abstract available.
-
Glomerular deposition of food antigens in IgA nephropathy.Clin Exp Immunol. 1988 Aug;73(2):295-9. Clin Exp Immunol. 1988. PMID: 3052946 Free PMC article.
-
Experimental IgA nephropathy: factors influencing IgA-immune complex deposition in the glomerulus.Springer Semin Immunopathol. 1994;16(1):97-103. doi: 10.1007/BF00196717. Springer Semin Immunopathol. 1994. PMID: 7997950 Review. No abstract available.
-
(E)-N-[(3,4-dimethoxyphenethyl)]-N-methyl-3-(3-pyridyl)-2-propenamide (TJN-331) inhibits mesangial expansion in experimental IgA nephropathy in ddY mice.Clin Exp Nephrol. 2010 Dec;14(6):528-35. doi: 10.1007/s10157-010-0338-4. Epub 2010 Sep 4. Clin Exp Nephrol. 2010. PMID: 20814808
MeSH terms
Substances
LinkOut - more resources
Miscellaneous